Joslin Diabetes Center, an affiliate of Harvard Medical School and the world’s preeminent diabetes care, research and education center, will convene hundreds of leaders and innovators in diabetes and obesity care and prevention at its 2nd Annual Diabetes Innovation Congress on October 3rd-5th at the Omni Shoreham Hotel in Washington, D.C.
Diabetes Innovation 2013 will bring together members of the patient, payer, provider and purchasing communities, as well as academia, industry and government, for an open exchange of ideas to work toward finding new solutions to catalyze improvements in the health system. Nearly 500 delegates representing these various constituencies attended the 2 ½ days and 40+ keynotes, interactive panels, exhibits and other sessions in 2012. In addition to the educational sessions, delegates had an opportunity for a hands-on look at the latest technologies, innovations and advancements in the Congress’ networking lounge from leading companies and solutions providers that have a stake in seeing diabetes care improve.
The diabetes epidemic demands a powerful response from leaders in the diabetes community, nationally and globally. By bringing together the best minds across payers, providers, industry, government, research, prevention and treatment, Diabetes Innovation 2013 will act as a powerful marketplace of ideas, partnerships and collaboration to provoke thought, innovation and action that address the cost, productivity and quality-of-life impacts of diabetes on our society.